Form 8-K - Current report:
SEC Accession No. 0001615219-25-000069
Filing Date
2025-07-14
Accepted
2025-07-14 08:33:35
Documents
14
Period of Report
2025-07-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20250710.htm   iXBRL 8-K 32706
2 EX-99.1 a071425slrxnasdaqfurtherex.htm EX-99.1 17580
6 image_0.jpg GRAPHIC 10804
  Complete submission text file 0001615219-25-000069.txt   187654

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20250710.xsd EX-101.SCH 1807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20250710_lab.xml EX-101.LAB 21689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20250710_pre.xml EX-101.PRE 12543
16 EXTRACTED XBRL INSTANCE DOCUMENT flks-20250710_htm.xml XML 2724
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)